MD Mednax Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$8.77

Market cap

$736.89M

P/E Ratio

10.57

Dividend/share

N/A

EPS

$0.83

Enterprise value

$1.42B

Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of ...

Highlights
The P/E is 90% below the last 4 quarters average of 104.5
The equity is up by 13% YoY and by 2.7% QoQ
The company's EPS has surged by 57% YoY but it fell by 12% QoQ
The net income rose by 11% year-on-year but it has declined by 9% since the previous quarter
The gross margin has declined by 13% year-on-year and by 2.7% since the previous quarter
Mednax's gross profit has decreased by 11% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.mednax.com
Peers: UHS CYH THC

Key stats

What are the main financial stats of MD
Market
Shares outstanding
84.02M
Market cap
$736.89M
Enterprise value
$1.42B
Valuations
Price to earnings (P/E)
10.57
Price to book (P/B)
0.76
Price to sales (P/S)
0.36
EV/EBIT
8.57
EV/EBITDA
7.04
EV/Sales
0.71
Earnings
Revenue
$2.01B
EBIT
$165.92M
EBITDA
$202.17M
Free cash flow
$133.42M
Per share
EPS
$0.83
Free cash flow per share
$1.62
Book value per share
$11.53
Revenue per share
$24.38
TBVPS
$9.43
Balance sheet
Total assets
$2.33B
Total liabilities
$1.36B
Debt
$706.92M
Equity
$967.99M
Working capital
$70.08M
Liquidity
Debt to equity
0.73
Current ratio
1.2
Quick ratio
1.15
Net debt/EBITDA
3.39
Margins
EBITDA margin
10%
Gross margin
21.7%
Net margin
4.6%
Operating margin
7.7%
Efficiency
Return on assets
4%
Return on equity
10.1%
Return on invested capital
14.2%
Return on capital employed
8.4%
Return on sales
8.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
4.65%
1 week
-0.79%
1 month
-21.77%
1 year
-46%
YTD
-40.98%
QTD
-31%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$2.01B
Gross profit
$436.21M
Operating income
$154.85M
Net income
$93.54M
Gross margin
21.7%
Net margin
4.6%
The operating margin has declined by 27% year-on-year and by 4.9% since the previous quarter
MD's operating income is down by 24% year-on-year and by 4.4% since the previous quarter
The gross margin has declined by 13% year-on-year and by 2.7% since the previous quarter
The net margin has decreased by 12% from the previous quarter but it has increased by 7% YoY

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
MD P/E details
P/E
10.57
P/B
0.76
P/S
0.36
EV/EBIT
8.57
EV/EBITDA
7.04
EV/Sales
0.71
The P/E is 90% below the last 4 quarters average of 104.5
The company's EPS has surged by 57% YoY but it fell by 12% QoQ
The P/B is 58% below the 5-year quarterly average of 1.8 and 42% below the last 4 quarters average of 1.3
The equity is up by 13% YoY and by 2.7% QoQ
The stock's price to sales (P/S) is 67% less than its 5-year quarterly average of 1.1 and 40% less than its last 4 quarters average of 0.6
The revenue has increased by 2.8% YoY

Efficiency

How efficient is Mednax business performance
The ROIC is up by 21% YoY but it is down by 2.7% from the previous quarter
The ROA has grown by 18% YoY but it has contracted by 9% from the previous quarter
MD's return on equity is down by 11% since the previous quarter but it is up by 4.1% year-on-year
The company's return on sales fell by 7% QoQ

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 71% greater than the total liabilities
The total liabilities has declined by 8% year-on-year
The company's current ratio fell by 3.2% QoQ
The debt is 27% less than the equity
MD's debt to equity is down by 23% year-on-year and by 8% since the previous quarter
The equity is up by 13% YoY and by 2.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.